Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
- PMID: 27771284
- PMCID: PMC5123944
- DOI: 10.1016/j.brainres.2016.10.018
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
Abstract
The orexin/hypocretin (ORX) system regulates motivation for natural rewards and drugs of abuse such as alcohol. ORX receptor antagonists, most commonly OX1R antagonists including SB-334867 (SB), decrease alcohol drinking, self-administration and reinstatement in both genetically-bred alcohol-preferring and outbred strains of rats. Importantly, levels of alcohol seeking and drinking in outbred rats are variable, as they are in humans. We have shown that OX1R antagonism selectively decreases homecage alcohol drinking in high-, but not low-alcohol-preferring rats. It is unknown, however, whether this effect is selective to homecage drinking or whether it also applies to alcohol seeking paradigms such as self-administration and reinstatement following extinction, in which motivation is high in the absence of alcohol. Here we trained Sprague Dawley rats to self-administer 20% ethanol paired with a light-tone cue on an FR3 regimen. Rats were then extinguished and subjected to cue-induced reinstatement. Rats were segregated into high- and low-ethanol-responding groups (HR and LR) based on self-administration levels. During self-administration and cue-induced reinstatement, rats were given SB or vehicle prior to ethanol seeking. In both conditions, OX1R antagonism decreased responding selectively in HR, but not LR rats. There were no non-specific effects of SB treatment on arousal or general behavior. These data indicate that ORX signaling at the OX1R receptor specifically regulates high levels of motivation for alcohol, even in the absence of direct alcohol reinforcement. This implicates the ORX system in the pathological motivation underlying alcohol abuse and alcoholism and demonstrates that the OX1R may be an important target for treating alcohol abuse.
Keywords: Alcoholism; Individual differences; Lateral hypothalamus; Motivation; Neuropeptide; Reward.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures





Similar articles
-
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats.Addict Biol. 2016 May;21(3):603-12. doi: 10.1111/adb.12251. Epub 2015 Apr 20. Addict Biol. 2016. PMID: 25899624
-
Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.Neuropsychopharmacology. 2009 Aug;34(9):2125-34. doi: 10.1038/npp.2009.37. Epub 2009 Mar 25. Neuropsychopharmacology. 2009. PMID: 19322167
-
Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.Int J Neuropsychopharmacol. 2013 Oct;16(9):2067-79. doi: 10.1017/S1461145713000333. Epub 2013 Apr 22. Int J Neuropsychopharmacol. 2013. PMID: 23601187
-
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.Psychopharmacology (Berl). 2018 Jun;235(6):1663-1680. doi: 10.1007/s00213-018-4871-2. Epub 2018 Mar 6. Psychopharmacology (Berl). 2018. PMID: 29508004 Free PMC article. Review.
-
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors.Neuropharmacology. 2020 May 15;168:108013. doi: 10.1016/j.neuropharm.2020.108013. Epub 2020 Feb 15. Neuropharmacology. 2020. PMID: 32092435 Review.
Cited by
-
Orbitofrontal Cortex Encodes Preference for Alcohol.eNeuro. 2020 Jul 16;7(4):ENEURO.0402-19.2020. doi: 10.1523/ENEURO.0402-19.2020. Print 2020 Jul/Aug. eNeuro. 2020. PMID: 32661066 Free PMC article.
-
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.Neuropharmacology. 2021 Feb 1;183:108359. doi: 10.1016/j.neuropharm.2020.108359. Epub 2020 Oct 19. Neuropharmacology. 2021. PMID: 33091458 Free PMC article. Review.
-
Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?".Brain Res. 2020 Mar 15;1731:146665. doi: 10.1016/j.brainres.2020.146665. Epub 2020 Jan 10. Brain Res. 2020. PMID: 31930996 Free PMC article. No abstract available.
-
Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease.Front Mol Biosci. 2020 Jan 31;7:5. doi: 10.3389/fmolb.2020.00005. eCollection 2020. Front Mol Biosci. 2020. PMID: 32118032 Free PMC article.
-
Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence.Front Integr Neurosci. 2020 Nov 10;14:599710. doi: 10.3389/fnint.2020.599710. eCollection 2020. Front Integr Neurosci. 2020. PMID: 33240054 Free PMC article.
References
-
- Alcaraz-Iborra M, Cubero I. Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug/food dependence? Pharmacology Biochemistry and Behavior. 2015;134:31–34. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical